Stockreport

ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chic...

Zivo Bioscience, Inc.  (ZIVO) 
NASDAQ:AMEX Investor Relations: zivobioscience.com
PDF in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces positive efficacy results following it [Read more]